Here’s what you need to know:
1. The firm sold MicroDental Laboratories to Modern Dental Group Limited, a global provider of dental prosthetic devices.
2. HealthpointCapital retained ProSomnus Sleep Technologies, a former division of MicroDental Laboratories, in the transaction.
3. ProSomnus Sleep Technologies manufactures oral appliances for obstructive sleep apnea and supports research concerning dental sleep medicine as therapy for obstructive sleep apnea.
4. Len Liptak has been named the CEO of ProSomnus Sleep Technologies.
5. The global obstructive sleep apnea market for therapeutic devices is expected to reach $6 billion by 2020, growing at a CAGR of 9 percent.
More articles on dental news:
Kool Smiles encourages children to donate candy to U.S. troops
St. Renatus launches 1st nasal spray dental anesthetic: 5 things to know
Does plaque identifying toothpaste really reduce inflammation? 5 study insights
